Sequential Endoluminal Gemcitabine and Cabazitaxel with Intravenous Pembrolizumab as a Bladder-Preserving Strategy for Docetaxel-Unresponsive Non-Muscle Invasive Urothelial Carcinoma Following…

Overview of attention for article published in Cancers, July 2024

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 5 Mendeley

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 5,635 followers.

RT @ZakhariaYousef: Another intravesicular regimen (cabazitaxel+ Gem) by Mike O'Donnell @UIowaCancer with pembro, in refractory HRNMIBC (D…

Another intravesicular regimen (cabazitaxel+ Gem) by Mike O'Donnell @UIowaCancer with pembro, in refractory HRNMIBC (Doce failure), interesting results, prospective study underway. Honored to be part of this effort. https://t.co/WKFCE7pRDh #mdpicance…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.